We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Warns OTC Manufacturer for Differences Between Electronic Records, Labeling
FDA Warns OTC Manufacturer for Differences Between Electronic Records, Labeling
The FDA issued a warning letter to Ami Cosmetics in Soeul, South Korea, saying the over-the-counter drugmaker had contradictory information in its labeling and its electronic listing in the FDA’s National Drug Code directory.